News
10-03-2010, 08:20 PM
Celsion Corporation announced today that interim data from its Phase I/II DIGNITY trial of ThermoDox in Recurrent Chest Wall (RCW) Breast Cancer were presented at the poster session at the 2010 Breast Cancer Symposium.
More... (http://www.news-medical.net/news/20101003/Celsion-presents-Phase-III-DIGNITY-trial-data-at-2010-Breast-Cancer-Symposium.aspx)
More... (http://www.news-medical.net/news/20101003/Celsion-presents-Phase-III-DIGNITY-trial-data-at-2010-Breast-Cancer-Symposium.aspx)